📰 Scientist Training Program News
Page 3 - Scientist Training Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Scientist Training Program. Real-time updates on events, politics, business and more.
December 12, 2023
A new study uncovers a molecular connection between vitamin B12 and multiple sclerosis (MS).
December 12, 2023
Lymphatic fluid from surgical drains, which is usually tossed in the trash, is a treasure in the hands of University of Pittsburgh and Washington University School of Medicine in St. Louis researchers who found that this liquid could inform more precise treatments for patients with head and neck cancer caused by human papillomavirus (HPV).
December 10, 2023
As Indigenous communities across the country hold celebrations for Native American Heritage Month, we note great achievements in the sciences by Native peoples. Whether in […]
November 30, 2023
UCLA students and community members have long awaited the opening of 99 Ranch Market. A ribbon cutting ceremony marked the end of the three-year wait Wednesday.
November 20, 2023
Tuberculosis, the world’s leading infectious disease killer, caused 1.6 million deaths in 2021, along with 10 million new cases of tuberculosis every year. Tuberculosis, the world’s leading infectious disease killer, cau...
October 23, 2023
A nationally renowned cancer biology researcher will chair UVA School of Medicine’s Department of Dermatology.
October 16, 2023
David A. Hunstad, MD, a respected pediatric infectious diseases specialist and a national leader in pediatric research training, has been named the inaugural Arnold W. Strauss, MD, Endowed Professor for Mentoring at Washington University School of Medicine in St. Louis.
September 26, 2023
In the summer of 2018, graduate student Hunter Dean from the Medical Scientist Training Program came to Yuhua Song, Ph.D., with a research idea. He wanted to pursue his doctoral research at the University of Alabama at Birmingham in Alzheimer’s disea
September 19, 2023
19.09.2023 - BRISBANE, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) - Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-classi therapeutics that combine both targeted and immune-mediated mechanisms, announced today ... Seite 1
September 15, 2023
Scientists used a new method to screen 10,000 combinations of gene edits in immune cells engineered to fight cancer